广发创新医疗两年持有混合A(010731)利润分配表
| |
2026-06-30 |
2025-12-31 |
2025-06-30 |
2024-12-31 |
| 收入 |
87,578,553.86 |
142,976,481.18 |
127,042,836.04 |
-37,386,315.21 |
| 利息合计 |
125,626.14 |
181,031.84 |
111,013.30 |
179,646.42 |
| 其中：存款利息收入 |
125,626.14 |
125,908.19 |
55,889.65 |
179,646.42 |
| 债券利息收入 |
- |
- |
- |
- |
| 资产支持证券利息收入 |
- |
- |
- |
- |
| 买入返售金融资产收入 |
- |
55,123.65 |
55,123.65 |
- |
| 投资收益合计 |
91,191,126.88 |
117,562,808.08 |
22,996,077.98 |
-48,295,487.30 |
| 其中：股票投资收益 |
90,363,081.99 |
115,446,720.95 |
21,489,808.38 |
-51,517,982.07 |
| 基金投资收益 |
- |
- |
- |
- |
| 债券投资收益 |
69,650.20 |
2,768.73 |
-1,975.55 |
31,020.63 |
| 资产支持证券投资收益 |
- |
- |
- |
- |
| 衍生工具收益 |
- |
- |
- |
- |
| 股利收益 |
758,394.69 |
2,113,318.40 |
1,508,245.15 |
3,191,474.14 |
| 基金分红收益收益 |
- |
- |
- |
- |
| 公允价值变动收益 |
-3,738,199.16 |
25,232,641.26 |
103,935,744.76 |
10,729,525.67 |
| 其他收入 |
- |
- |
- |
- |
| 费用 |
3,360,860.84 |
6,174,440.62 |
2,747,624.26 |
5,501,683.80 |
| 管理人报酬 |
2,651,707.79 |
4,856,509.67 |
2,151,875.60 |
4,297,303.88 |
| 基金托管费 |
441,951.30 |
809,418.26 |
358,645.87 |
716,217.26 |
| 销售服务费 |
175,933.03 |
320,587.07 |
145,246.57 |
304,822.49 |
| 交易费用 |
- |
- |
- |
- |
| 利息支出 |
- |
- |
- |
- |
| 其中：卖出回购金融资产支出 |
- |
- |
- |
- |
| 其他费用 |
91,050.23 |
187,925.62 |
91,856.22 |
183,340.05 |
| 利润总额 |
84,217,693.02 |
136,802,040.56 |
124,295,211.78 |
-42,887,999.01 |
微信公众号
证券之星APP
基本资料
